202 related articles for article (PubMed ID: 9556603)
1. Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors.
Honer M; Benke D; Laube B; Kuhse J; Heckendorn R; Allgeier H; Angst C; Monyer H; Seeburg PH; Betz H; Mohler H
J Biol Chem; 1998 May; 273(18):11158-63. PubMed ID: 9556603
[TBL] [Abstract][Full Text] [Related]
2. [3H]CGP 61594, the first photoaffinity ligand for the glycine site of NMDA receptors.
Benke D; Honer M; Heckendorn R; Pozza MF; Allgeier H; Angst C; Mohler H
Neuropharmacology; 1999 Feb; 38(2):233-42. PubMed ID: 10218864
[TBL] [Abstract][Full Text] [Related]
3. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
Laurie DJ; Seeburg PH
Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.
Buller AL; Larson HC; Schneider BE; Beaton JA; Morrisett RA; Monaghan DT
J Neurosci; 1994 Sep; 14(9):5471-84. PubMed ID: 7916045
[TBL] [Abstract][Full Text] [Related]
5. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
6. Molecular distinction of three N-methyl-D-aspartate-receptor subtypes in situ and developmental receptor maturation demonstrated with the photoaffinity ligand 125I-labeled CGP 55802A.
Marti T; Benke D; Mertens S; Heckendorn R; Pozza M; Allgeier H; Angst C; Laurie D; Seeburg P; Mohler H
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8434-8. PubMed ID: 8378316
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.
Malayev A; Gibbs TT; Farb DH
Br J Pharmacol; 2002 Feb; 135(4):901-9. PubMed ID: 11861317
[TBL] [Abstract][Full Text] [Related]
8. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
Madry C; Mesic I; Betz H; Laube B
Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of a glycine-binding fragment of the N-methyl-D-aspartate receptor subunit NR1.
Miyazaki J; Nakanishi S; Jingami H
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):687-92. PubMed ID: 10359652
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes.
Grimwood S; Le Bourdellès B; Atack JR; Barton C; Cockett W; Cook SM; Gilbert E; Hutson PH; McKernan RM; Myers J; Ragan CI; Wingrove PB; Whiting PJ
J Neurochem; 1996 Jun; 66(6):2239-47. PubMed ID: 8632144
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
[TBL] [Abstract][Full Text] [Related]
14. The integrity of the glycine co-agonist binding site of N-methyl-D-aspartate receptors is a functional quality control checkpoint for cell surface delivery.
Kenny AV; Cousins SL; Pinho L; Stephenson FA
J Biol Chem; 2009 Jan; 284(1):324-333. PubMed ID: 18990687
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the binding of two novel glycine site antagonists to cloned NMDA receptors: evidence for two pharmacological classes of antagonists.
Chopra B; Chazot PL; Stephenson FA
Br J Pharmacol; 2000 May; 130(1):65-72. PubMed ID: 10780999
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acid residues of the NR2A subunit that control glutamate potency in recombinant NR1/NR2A NMDA receptors.
Anson LC; Chen PE; Wyllie DJ; Colquhoun D; Schoepfer R
J Neurosci; 1998 Jan; 18(2):581-9. PubMed ID: 9425000
[TBL] [Abstract][Full Text] [Related]
17. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
Monaghan DT; Larsen H
J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
[TBL] [Abstract][Full Text] [Related]
18. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
Williams K
Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
[TBL] [Abstract][Full Text] [Related]
19. [3H]MDL 105,519 binds with equal high affinity to both assembled and unassembled NR1 subunits of the NMDA receptor.
Chazot PL; Reiss C; Chopra B; Stephenson FA
Eur J Pharmacol; 1998 Jul; 353(1):137-40. PubMed ID: 9721050
[TBL] [Abstract][Full Text] [Related]
20. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
